Co-Diagnostics (CODX) announced a private placement agreement with institutional investors to sell 1.65M shares of common stock, or pre-funded warrants in lieu of shares, along with warrants to ...

Co-Diagnostics, Inc. CODX stock is trading higher on Wednesday as the company announced a private placement aimed at raising ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx", or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced ...

May 14, 2026 at 4:30 p.m. ET. CALL PARTICIPANTS. Chief Executive Officer — Dwight Egan; Chief Financial Officer — Brian Brown ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that ...

The molecular diagnostics firm revealed it has signed a Memorandum of Understanding with a Saudi Arabian partner to potentially create a joint venture aimed at developing and distributing its Co-Dx™ ...

Co-Diagnostics, Inc. (NASDAQ:CODX) announced on Monday that it has entered into a joint venture agreement with the Kingdom of Saudi Arabia (KSA) based Arabian Eagle Manufacturing. The agreement aims ...

Co-Diagnostics Inc. Annual cash flow by MarketWatch. View CODX net cash flow, operating cash flow, operating expenses and cash dividends.

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Co-Diagnostics (CODX) is a stock that can certainly grab the attention of many ...